April 5, 2017
Marina Biotech released a corporate update detailing recent changes in the company and some corporate highlights, following the filing of...
April 3, 2017
Marina Biotech signed an agreement with Windlas Healthcare Limited to manufacture IT-102 fixed-dose combination bi-layer tablets.
March 29, 2017
Marina Biotech will showcase new scientific information on the use of IT-102 and IT-103 for cancer treatment during the American...
March 24, 2017
Marina Biotech (OTCQB:MRNA) will present new information on the use of antihypertensive for the treatment of cancer by targeting vascular...
March 13, 2017
Marina Biotech (OTCQB: MRNA) announced it will present an update at the Society of Toxicology 56th Annual Meeting in March.